D.E. Shaw & Co
EVFM

D.E. Shaw & Co’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

D.E. Shaw & Co’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-32,782
Closed -$167K – 6085
2022
Q1 		$167K Sell
32,782
-117,880
-78% -$741K ﹤0.01% 4911
2021
Q4 		$848K Sell
150,662
-149,493
-50% -$1.27M ﹤0.01% 4067
2021
Q3 		$3.33M Sell
300,155
-2,414
-0.8% -$30.3K ﹤0.01% 2519
2021
Q2 		$5.13M Buy
302,569
+254,518
+530% +$4.82M 0.01% 2014
2021
Q1 		$1.26M Buy
48,051
+35,084
+271% +$1.59M ﹤0.01% 2928
2020
Q4 		$469K Buy
+12,967
New +$469K ﹤0.01% 3420
2020
Q3 		– Sell
-755
Closed -$32K – 4353
2020
Q2 		$32K Buy
+755
New +$50.9K ﹤0.01% 3936

Other funds holding EVFM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return